1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cannabis Strategic Ventures

Cannabis Strategic Ventures

NUGS
Cannabis Strategic VenturesUS flagOther OTC
0.00
USD
- -
- -
243,864.00Market Cap

Total Valuation

Cannabis Strategic Ventures carries a market capitalization of 243,864.00, placing it among publicly traded companies globally. Its enterprise value stands at 42.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap243,864.00
Enterprise Value42.99M

Share Statistics

Cannabis Strategic Ventures currently has 268.88M shares outstanding.

Shares Outstanding268.88M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 3.70, and the price-to-book ratio stands at -0.45.

PE RatioN/A
PS Ratio3.70
PB Ratio-0.45
P/TBV Ratio-3.08
P/FCF Ratio-2.69
P/OCF Ratio-2.48

Enterprise Valuation

EV / Sales7.49
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Cannabis Strategic Ventures maintains a current ratio of 0.27, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -327.39, indicating conservative leverage, while an interest coverage ratio of -360.46 demonstrates limited ability to service its debt obligations.

Current Ratio0.27
Quick Ratio0.09
Debt / Equity-327.39
Debt / EBITDA-2.71
Interest Coverage-360.46

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-60.50
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.57

Stock Price Statistics

Cannabis Strategic Ventures's stock has gained approximately 1200.00004% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change1200.00004%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Cannabis Strategic Ventures generated 5.74M in revenue and converted that into -10.48M in net income, yielding earnings per share of -0.04. EBITDA reached -8.18M, while operating income came in at -8.38M.

Revenue5.74M
Gross Profit1.37M
Operating Income-8.38M
Pretax Income-10.50M
Net Income-10.48M
EBITDA-8.18M
EBIT-8.38M
Earnings Per Share (EPS)-0.04

Balance Sheet

Cannabis Strategic Ventures holds 456,630.00 in cash and equivalents against 22.20M in total debt, resulting in a net debt position of 12.77M. Total book value stands at -46.71M, with working capital of -12.47M providing operational flexibility.

Cash & Cash Equivalents456,630.00
Total Debt22.20M
Net Debt12.77M
Equity (Book Value)-46.71M
Book Value Per Share-0.17
Working Capital-12.47M

Cash Flow

Cannabis Strategic Ventures produced -8.56M in operating cash flow over the past twelve months. After subtracting -667,746.00 in capital expenditures, free cash flow totaled -9.23M - equivalent to -0.03 per share.

Operating Cash Flow-8.56M
Capital Expenditures-667,746.00
Free Cash Flow-9.23M
FCF Per Share-0.03

Margins

Cannabis Strategic Ventures operates with a gross margin of 23.90, reflecting its pricing power and cost economics. The operating margin of -146.02 and net profit margin of -182.55 provide insight into operational efficiency.

Gross Margin23.90
Operating Margin-146.02
Pretax Margin-182.92
Profit Margin-182.55
EBITDA Margin-142.46

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-44.64
FCF Yield-37.18

Stock Splits

Cannabis Strategic Ventures's most recent stock split took place on April 29, 2015 with a 25:1 split ratio.

Last Split Date4/29/2015
Split Ratio25:1

Scores

Cannabis Strategic Ventures posts an Altman Z-Score of -5.42, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-5.42